Translate
Apellis Pharmaceuticals, Inc.
About
Apellis Pharmaceuticals, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 31 2026
Biogen to Acquire Apellis, Enhancing the Company’s Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology
Mar 2 2026
Apellis Announces Mikael Dolsten, M.D., Ph.D., to Join Board of Directors
Feb 24 2026
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
Feb 23 2026
Apellis Pharmaceuticals to Present at the TD Cowen 46th Annual Health Care Conference
Feb 19 2026
Apellis Announces Eight Oral Presentations at the 49th Macula Society Annual Meeting
Recent Videos
APELLIS PHARMACEUTICALS INC: WHAT HAPPENED? - CROWDSTRIKE HOLDINGS INC: NICE TAKE PROFIT AT $564!
May 16, 2026
Apellis Q1 Preview: Biogen Deal Closing Soon
May 10, 2026
Apellis Pharmaceuticals (APLS) Stock Analysis 2026 | Is APLS Still a Buy After 134% Rally?
Apr 28, 2026
Thursday, April 9, 2026 11AM UTC – Daily News: Apellis…
Apr 09, 2026
Community Chat
Ask AI
Try asking